Back

Residual risk in chronic coronary syndrome: beyond revascularization, LDL and thrombosis

16 October 2026 (08:48 - 09:00)
Organised by:
Seminar Presentation Part of: Chronic coronary artery disease: evolution of the concept and diagnostic strategies Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) Open Access ESC in LATAM 2026

About the speaker

Photo
Professor Eva Prescott

Bispebjerg University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Plaque assessment by computed tomography: quantification, characterisation, and vulnerability markers for the clinical cardiologist
Presentation thumbnail
Coronary interventions guided by high-definition coronary CT angiography
Presentation thumbnail
Vulnerable plaque: is optimal medical therapy enough?
Presentation thumbnail
Multivessel disease: is ischemia still the main prognostic determinant? Contemporary treatment of ischemic cardiomyopathy
Presentation thumbnail
Chronic coronary artery disease: evolution of the concept and diagnostic strategies - Discussion

Access the full session

Session thumbnail
Chronic coronary artery disease: evolution of the concept and diagnostic strategies

The Event

Event poster

ESC in LATAM 2026

16 October 2026 08:48 CET
You may be interested in
thumbnail
Congress Presentation
Deescalating measures for chronic coronary syndrome: as stable as an atherosclerotic plaque can be.
29 June 2021
thumbnail
Congress Session
Assessing and treating 'residual risk' beyond low-density lipoproteins
31 August 2026
thumbnail
Congress Presentation
Risk factors control, remnant cholesterol, recurrent events and risk in patients with coronary heart disease. Our experiences
4 April 2025
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources